 Dennis Coalson
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychomotor Performance | 27 | 2012 | 510 | 1.610 |
Why?
| | Oxycodone | 3 | 2012 | 29 | 1.370 |
Why?
| | Carisoprodol | 2 | 2011 | 4 | 0.940 |
Why?
| | Narcotics | 3 | 2012 | 70 | 0.930 |
Why?
| | Analgesics, Opioid | 3 | 2014 | 372 | 0.770 |
Why?
| | Nitrous Oxide | 17 | 1999 | 105 | 0.610 |
Why?
| | Muscle Relaxants, Central | 2 | 2011 | 12 | 0.580 |
Why?
| | Morphine | 3 | 2014 | 136 | 0.580 |
Why?
| | Cross-Over Studies | 15 | 2014 | 413 | 0.550 |
Why?
| | Double-Blind Method | 21 | 2014 | 1899 | 0.540 |
Why?
| | Naltrexone | 1 | 2014 | 125 | 0.500 |
Why?
| | Alprazolam | 1 | 2012 | 2 | 0.490 |
Why?
| | GABA Modulators | 1 | 2012 | 9 | 0.490 |
Why?
| | Neurotoxicity Syndromes | 1 | 2011 | 26 | 0.470 |
Why?
| | Cognition | 8 | 2011 | 497 | 0.470 |
Why?
| | Analgesics | 2 | 2011 | 125 | 0.470 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2011 | 103 | 0.450 |
Why?
| | Affect | 16 | 2011 | 389 | 0.430 |
Why?
| | Memory | 4 | 2012 | 223 | 0.430 |
Why?
| | Anticonvulsants | 1 | 2011 | 129 | 0.420 |
Why?
| | Drug Interactions | 6 | 2012 | 271 | 0.360 |
Why?
| | Emotions | 1 | 2011 | 299 | 0.360 |
Why?
| | Methionine | 2 | 2019 | 66 | 0.250 |
Why?
| | Anesthetics, Inhalation | 6 | 1999 | 96 | 0.240 |
Why?
| | Adult | 30 | 2014 | 25955 | 0.210 |
Why?
| | Young Adult | 4 | 2014 | 5959 | 0.200 |
Why?
| | Narcotic Antagonists | 2 | 2014 | 150 | 0.170 |
Why?
| | Male | 30 | 2014 | 41844 | 0.170 |
Why?
| | Female | 28 | 2014 | 44708 | 0.160 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2011 | 2100 | 0.150 |
Why?
| | Pupil | 2 | 2014 | 19 | 0.150 |
Why?
| | Fentanyl | 3 | 1996 | 68 | 0.140 |
Why?
| | Substance-Related Disorders | 3 | 2011 | 381 | 0.140 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2014 | 89 | 0.140 |
Why?
| | Receptors, Opioid, mu | 1 | 2014 | 47 | 0.140 |
Why?
| | Propofol | 4 | 1996 | 96 | 0.140 |
Why?
| | Infusions, Intravenous | 2 | 2014 | 448 | 0.140 |
Why?
| | Humans | 38 | 2019 | 83081 | 0.130 |
Why?
| | Anesthetics, Intravenous | 3 | 1997 | 50 | 0.120 |
Why?
| | Toxicity Tests, Acute | 1 | 2011 | 2 | 0.120 |
Why?
| | Thinking | 1 | 2012 | 22 | 0.120 |
Why?
| | Respiratory Rate | 1 | 2011 | 18 | 0.120 |
Why?
| | Analgesia, Obstetrical | 1 | 1991 | 19 | 0.120 |
Why?
| | Reaction Time | 2 | 2012 | 315 | 0.110 |
Why?
| | S-Adenosylmethionine | 2 | 2019 | 13 | 0.110 |
Why?
| | Drug Combinations | 1 | 2011 | 245 | 0.110 |
Why?
| | Neuropsychological Tests | 2 | 2012 | 451 | 0.110 |
Why?
| | Heart Rate | 1 | 2014 | 559 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2011 | 122 | 0.100 |
Why?
| | Analgesia | 2 | 1999 | 56 | 0.100 |
Why?
| | Respiration Disorders | 1 | 1989 | 42 | 0.090 |
Why?
| | Methyl Ethers | 2 | 1999 | 33 | 0.090 |
Why?
| | Pain Measurement | 4 | 1999 | 304 | 0.090 |
Why?
| | Analgesics, Non-Narcotic | 2 | 1999 | 50 | 0.090 |
Why?
| | Naloxone | 2 | 1999 | 52 | 0.090 |
Why?
| | Thiopental | 2 | 1997 | 14 | 0.080 |
Why?
| | Midazolam | 2 | 1996 | 53 | 0.080 |
Why?
| | Isoflurane | 2 | 1996 | 63 | 0.080 |
Why?
| | Mental Recall | 3 | 1995 | 125 | 0.070 |
Why?
| | Administration, Inhalation | 7 | 1999 | 179 | 0.070 |
Why?
| | Neoplasms | 1 | 2019 | 2672 | 0.070 |
Why?
| | S-Adenosylhomocysteine | 2 | 2019 | 8 | 0.060 |
Why?
| | Anesthesia, Intravenous | 2 | 1996 | 37 | 0.060 |
Why?
| | Hypnotics and Sedatives | 2 | 1996 | 131 | 0.060 |
Why?
| | Homocysteine | 2 | 2019 | 31 | 0.060 |
Why?
| | Hemodynamics | 3 | 1996 | 710 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2014 | 7886 | 0.060 |
Why?
| | Cold Temperature | 3 | 1996 | 161 | 0.060 |
Why?
| | Psychomotor Disorders | 2 | 1997 | 21 | 0.050 |
Why?
| | Neoplasms, Experimental | 1 | 1982 | 284 | 0.050 |
Why?
| | Anesthetics, Combined | 1 | 1999 | 4 | 0.050 |
Why?
| | Drug Tolerance | 2 | 1996 | 70 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2019 | 2 | 0.050 |
Why?
| | Anesthesia Recovery Period | 2 | 1996 | 75 | 0.050 |
Why?
| | Methylation | 2 | 2019 | 240 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2019 | 321 | 0.050 |
Why?
| | Ethers | 1 | 1997 | 17 | 0.050 |
Why?
| | Cell Transformation, Viral | 3 | 1982 | 44 | 0.050 |
Why?
| | Injections, Intravenous | 5 | 1996 | 269 | 0.050 |
Why?
| | Anti-Anxiety Agents | 1 | 1996 | 22 | 0.040 |
Why?
| | Euphoria | 2 | 1995 | 47 | 0.040 |
Why?
| | Anesthesia, Inhalation | 1 | 1996 | 37 | 0.040 |
Why?
| | Central Nervous System Depressants | 1 | 1997 | 62 | 0.040 |
Why?
| | Wakefulness | 1 | 1996 | 131 | 0.040 |
Why?
| | Flumazenil | 1 | 1995 | 8 | 0.040 |
Why?
| | Arousal | 2 | 1993 | 169 | 0.040 |
Why?
| | Pain Threshold | 1 | 1995 | 53 | 0.040 |
Why?
| | Butorphanol | 1 | 1994 | 10 | 0.040 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 242 | 0.030 |
Why?
| | Motivation | 1 | 1996 | 258 | 0.030 |
Why?
| | Simian virus 40 | 3 | 1982 | 34 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 1997 | 272 | 0.030 |
Why?
| | Meperidine | 1 | 1993 | 15 | 0.030 |
Why?
| | Substance Abuse, Intravenous | 1 | 1993 | 49 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 2422 | 0.030 |
Why?
| | Behavior | 1 | 1993 | 91 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2019 | 1611 | 0.030 |
Why?
| | Medical History Taking | 1 | 1992 | 83 | 0.030 |
Why?
| | Transcutaneous Electric Nerve Stimulation | 1 | 1991 | 10 | 0.030 |
Why?
| | Anesthesia, Obstetrical | 1 | 1991 | 25 | 0.030 |
Why?
| | Health Status Indicators | 1 | 1992 | 104 | 0.030 |
Why?
| | Oxygen | 4 | 1999 | 719 | 0.030 |
Why?
| | Ethanol | 1 | 1993 | 299 | 0.030 |
Why?
| | Alfentanil | 1 | 1989 | 3 | 0.020 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 1992 | 325 | 0.020 |
Why?
| | Prospective Studies | 4 | 1996 | 4067 | 0.020 |
Why?
| | Recurrence | 1 | 1989 | 1194 | 0.020 |
Why?
| | Infant, Newborn | 1 | 1991 | 2430 | 0.020 |
Why?
| | Pregnancy | 1 | 1991 | 2809 | 0.020 |
Why?
| | Choice Behavior | 2 | 1997 | 160 | 0.020 |
Why?
| | Reference Values | 2 | 1994 | 699 | 0.020 |
Why?
| | Pteroylpolyglutamic Acids | 1 | 1981 | 1 | 0.020 |
Why?
| | Folic Acid | 1 | 1981 | 45 | 0.010 |
Why?
| | Fibroblasts | 2 | 1981 | 727 | 0.010 |
Why?
| | Cell Division | 1 | 1982 | 749 | 0.010 |
Why?
| | Methyltransferases | 1 | 1981 | 171 | 0.010 |
Why?
| | Cell Line | 2 | 1982 | 2614 | 0.010 |
Why?
| | Blood Pressure | 2 | 1996 | 1196 | 0.010 |
Why?
| | Mental Competency | 1 | 1997 | 47 | 0.010 |
Why?
| | Immersion | 1 | 1996 | 21 | 0.010 |
Why?
| | Motor Skills | 1 | 1996 | 77 | 0.010 |
Why?
| | Single-Blind Method | 1 | 1996 | 158 | 0.010 |
Why?
| | DNA | 1 | 1981 | 1300 | 0.010 |
Why?
| | Informed Consent | 1 | 1997 | 242 | 0.010 |
Why?
| | Miosis | 1 | 1994 | 10 | 0.010 |
Why?
| | Patient Discharge | 1 | 1996 | 221 | 0.010 |
Why?
| | Reflex, Pupillary | 1 | 1994 | 7 | 0.010 |
Why?
| | Cognition Disorders | 1 | 1996 | 240 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 1996 | 990 | 0.010 |
Why?
| | Middle Aged | 2 | 1992 | 25586 | 0.010 |
Why?
| | Pulse | 1 | 1992 | 22 | 0.010 |
Why?
| | Attitude to Computers | 1 | 1992 | 12 | 0.010 |
Why?
| | Preventive Medicine | 1 | 1992 | 21 | 0.010 |
Why?
| | Individuality | 1 | 1993 | 104 | 0.010 |
Why?
| | Pain | 1 | 1995 | 360 | 0.010 |
Why?
| | Attention | 1 | 1996 | 365 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1992 | 307 | 0.010 |
Why?
| | Anesthesia | 1 | 1993 | 171 | 0.010 |
Why?
| | Time Factors | 2 | 1996 | 5497 | 0.010 |
Why?
| | Interviews as Topic | 1 | 1992 | 331 | 0.010 |
Why?
| | Learning | 1 | 1993 | 262 | 0.010 |
Why?
| | Anesthesiology | 1 | 1992 | 163 | 0.010 |
Why?
| | Health Status | 1 | 1992 | 363 | 0.010 |
Why?
| | Preoperative Care | 1 | 1992 | 419 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1996 | 3877 | 0.010 |
Why?
| | gamma-Glutamyl Hydrolase | 1 | 1981 | 1 | 0.000 |
Why?
| | Chromatography, Gel | 1 | 1981 | 114 | 0.000 |
Why?
| | 5-Methylcytosine | 1 | 1981 | 94 | 0.000 |
Why?
| | Cytosine | 1 | 1981 | 123 | 0.000 |
Why?
| | United States | 1 | 1992 | 6296 | 0.000 |
Why?
| | Aged | 1 | 1992 | 18483 | 0.000 |
Why?
|
|
Coalson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|